How HOXA9 may direct the evolution of blood cancers
Laure Talarmain, a PhD student who recently left the group has written up a blog on our recent paper in Nature Communications. Strongly recommended read on some of the thinking behind the paper!
Our new preprint on the dynamics and impact of p53 mutation at different stages of carcinogenesis reveals new insights into the role of this ubiquitous tumour suppressor (https://www.biorxiv.org/conte